Search Results 271-280 of 18942 for Neoplasm

  1. (Apex) CGT9486 in Patients With Advanced Systemic Mastocytosis - Mayo Clinic

    (ASM), System Mastocytosis (SM) with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL). Participation eligibility. Participant ...

  2. Akira Kawashima, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Kawashima's research also extends to applications of MRI for evaluating patients with non-neoplastic prostate conditions, contributing to the overall ...

  3. J Mark McKinney, M.D. - Mayo Clinic Faculty Profiles

    ... neoplasms; and percutaneous ablative techniques for neoplasms. He is also involved in academia and has cowritten publications on interventional radiology ...

  4. ... NEOPLASM WITH MCC,115442.5 MS657,KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC,62745.96 MS658,KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC ...

  5. Acute myelogenous leukemia - Symptoms and causes - Mayo Clinic

    Learn about this cancer that forms in the blood and bone marrow. Treatments include medicines and bone marrow transplant, also called stem cell transplant.

  6. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess tumor cells from blood and bone marrow from patients with myeloid neoplasms for epigenetic dysregulation and ...

  7. Publications - Sara K. Daniel, M.D. - Mayo Clinic

    Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms. Cancer. 2025 Jul 1; 131 (13):e35871. View PubMed; Su DG, Brown ...

  8. Publications - Aruna Rangan, M.B.B.S. - Mayo Clinic

    ... neoplasms. Am J Hematol 2024 Sep; 99 (9):1841-1844 Epub 2024 June 25 ... BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia.

  9. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess tumor cells from blood and bone marrow from patients with myeloid neoplasms for epigenetic dysregulation and ...

  10. Ayalew Tefferi, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Ayalew Tefferi, M.D., studies the pathophysiology, natural history and treatment of chronic myeloproliferative neoplasms (MPN).